VAUGHAN, ON , Dec. 22, 2022 /PRNewswire/ — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, today announced that the Company and its TOP DOG, Joseph C. Papa ,   have entered into an Amended and Restated Separation Agreement (the “Amended Splitting up Agreement”), pursuant to which Mr. Papa has agreed to continue serving as CEO until at least March 4, 2023 and lasting until such date because the Board of Directors of the particular Company determines in its discretion or his successor is appointed, but no later than June 30, 2023 . The Amended Separation Agreement also made certain changes to Mister. Papa’s compensation in connection with their separation from the Organization.

About Bausch + Lomb
Bausch + Lomb is focused on protecting plus enhancing the gift of sight for millions associated with people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter items and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has the significant worldwide research and development, manufacturing and commercial footprint with more than 12, 000 employees and a presence in nearly 100 countries. Bausch + Lomb will be headquartered within Vaughan, Ontario with corporate offices in Bridgewater , New Jersey.   For more information, visit and connect with us on Twitter , LinkedIn , Facebook and Instagram .

Forward-looking Statements
This news release may contain forward-looking statements, which may generally be identified by the use of the words “anticipates, ” “hopes, inch “expects, ” “intends, inch “plans, ” “should, inch “could, ” “would, inch “may, ” “believes, inch “estimates, ” “potential, inch “target, ” or “continue” and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks plus uncertainties that could cause actual results to differ materially from those described within the forward-looking statements. These types of risks and uncertainties include, but are not limited in order to, the risks plus uncertainties discussed in Bausch + Lomb’s filings along with the U. S. Securities and Exchange Commission and the Canadian Investments Administrators, which factors are usually incorporated herein by reference. They furthermore include, but are not limited to, risks and uncertainties caused simply by or relating to the particular evolving COVID-19 pandemic, as well as the fear associated with that pandemic as well as potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which might have a material adverse impact on Bausch + Lomb, including but not limited to its project development timelines, launches plus costs (which may increase). Readers are usually cautioned not to place undue reliance on any of these forward-looking claims. These forward-looking statements speak only as of the date hereof. Bausch + Lomb undertakes no obligation in order to update some of these forward-looking statements to reflect events or circumstances after the date of this news release or to reveal actual outcomes, unless required by law.

© 2022 Bausch & Lomb Incorporated or its affiliates.  

Investor Contact:                                

Media Contact:

Arthur Shannon                                     

Lainie Keller

[email protected]                

[email protected]

(908) 927-1198

Allison Ryan                                             

[email protected]      

(877) 354-3705 (toll free)   

(908) 927-0735                                       

SOURCE Bausch + Lomb Corporation

Leave a Reply

Your email address will not be published. Required fields are marked *